ASCVD risk equivalents
Clinical conditions that confer the same cardiovascular risk as established atherosclerotic disease. Used to guide intensity of preventive therapy.
Full Definition
ASCVD risk equivalents are clinical conditions that carry a cardiovascular event risk comparable to patients with established atherosclerotic cardiovascular disease, typically >20% 10-year risk. These conditions include diabetes mellitus in certain populations, chronic kidney disease with reduced eGFR, and familial hypercholesterolemia. Recognition of risk equivalents allows clinicians to initiate high-intensity preventive therapies without requiring formal risk calculation. The concept helps identify patients who benefit from aggressive lipid-lowering therapy regardless of calculated risk scores.
Usage
Usage note: Distinguish from 'risk enhancers' which modify calculated risk rather than replace it.
In Context
- "Patients with diabetes and additional risk factors are considered ASCVD risk equivalents requiring high-intensity statin therapy." — Clinical guideline document
- "The presence of chronic kidney disease with eGFR <60 mL/min/1.73m² qualifies as an ASCVD risk equivalent in current prevention guidelines." — Medical journal article